Senior insider sale
See Remarks at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$188.9K
60.82K shares
What this filing means
SHAH GAURAV plans to sell 60.82K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $188.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/21/2026ACC: 0001959173-26-003871
DirectorOfficer· See Remarks
Since Jan 2019
60.82K
Shares to sell
$188.9K
Approx. market value
55.68K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Option Granted - 04/12/2017
Cash
5/21/2026
55.68KTotal acquired55.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/21/2026 | Option Granted - 04/12/2017 Cash | 55.68K | — |
| Total | 55.68K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.41K
Market value
$7.3K
5/19/2026
—Completed
Units to sell
2.73K
Market value
$9.8K
5/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
55.68K
Market value
$171.8K
5/21/2026
Total
Units
60.82K
Value
$188.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/19/2026 | 2.41K | $7.3K | — | Completed |
5/13/2026 | 2.73K | $9.8K | — | Completed |
| Planned — Approximate Date | ||||
5/21/2026 | 55.68K | $171.8K | NASDAQ | Planned |
| Total | 60.82K | $188.9K | ||